|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1994-9-1
|
|
pubmed:abstractText |
To determine whether deferoxamine prevents the complications of transfusional iron overload in thalassemia major, we evaluated 59 patients (30 were female and 29 male; age range, 7 to 31 years) periodically for 4 to 10 years or until death.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
331
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
567-73
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8047080-Adolescent,
pubmed-meshheading:8047080-Adult,
pubmed-meshheading:8047080-Blood Transfusion,
pubmed-meshheading:8047080-Chelation Therapy,
pubmed-meshheading:8047080-Child,
pubmed-meshheading:8047080-Confidence Intervals,
pubmed-meshheading:8047080-Deferoxamine,
pubmed-meshheading:8047080-Female,
pubmed-meshheading:8047080-Humans,
pubmed-meshheading:8047080-Iron,
pubmed-meshheading:8047080-Liver,
pubmed-meshheading:8047080-Male,
pubmed-meshheading:8047080-Proportional Hazards Models,
pubmed-meshheading:8047080-Prospective Studies,
pubmed-meshheading:8047080-Risk,
pubmed-meshheading:8047080-Treatment Outcome,
pubmed-meshheading:8047080-beta-Thalassemia
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
|
|
pubmed:affiliation |
Department of Medicine, Case Western Reserve University, Cleveland, OH.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
